Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases

Biomarker assisted preclinical/early detection and intervention in Alzheimer’s disease (AD) may be the key to therapeutic breakthroughs. One of the presymptomatic hallmarks of AD is the accumulation of beta-amyloid (Aβ) plaques in the human brain. However, current methods to detect Aβ pathology are...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jianfeng, Dong, Qunxi, Gui, Jie, Zhang, Jie, Su, Yi, Chen, Kewei, Thompson, Paul M., Caselli, Richard J., Reiman, Eric M., Ye, Jieping, Wang, Yalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377280/
https://www.ncbi.nlm.nih.gov/pubmed/34421510
http://dx.doi.org/10.3389/fnins.2021.669595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377280/
https://www.ncbi.nlm.nih.gov/pubmed/34421510
http://dx.doi.org/10.3389/fnins.2021.669595

Ejemplares similares